glp 1 drugs pancreatitis GLP-1 Agonists and Risk Suspected drug-induced pancreatitis was rare

2005 May;26(2):19-39

Despite likely being a similar tier as GLP-1 RAs and SGLT2is for many patient insurances, this elevated AWP is important to note for patients with co-insurances, deductibles, the Medicare coverage gap, patients without insurance, and for the total cost of healthcare

Evidence for the adverse effect of starvation on bone quality: A review of the literature

Dr Wong Siu Kwan, a general practitioner and founder of Amber Family Clinic, said that in her experience, some people with BMI within the normal range tend to view GLP-1 drugs as suitable for cosmetic use or as over-the-counter weight-loss medicines

High-cost franchises mean many patients may be priced out or denied coverage